The Traderszone Network

Published in TZ Latest News 9 June, 2015 by The TZ Newswire Staff

FDA panel backs first-in-class cholesterol drug from Sanofi

Federal health advisers are recommending approval for a highly-anticipated cholesterol drug, but with the caveat that more data is needed about its long-term ability to reduce heart attacks. A panel of …